• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中国杜氏和贝克肌营养不良症患者的患病率及特征:香港一项全地区协作研究

Prevalence and Characteristics of Chinese Patients With Duchenne and Becker Muscular Dystrophy: A Territory Wide Collaborative Study in Hong Kong.

作者信息

Chan Sophelia H S, Lo Ivan F M, Cherk Sharon W W, Cheng Wai Wai, Fung Eva L W, Yeung Wai Lan, Ngan Mary, Lee Wing Cheong, Kwong Ling, Wong Suet Na, Ma Che Kwan, Tai Shuk Mui, Ng Grace S F, Wu Shun Ping, Wong Virginia C N

机构信息

Department of Paediatrics and Adolescent Medicine, Queen Mary Hospital, The University of Hong Kong, Hong Kong SAR, China.

Department of Health, Clinical Genetic Services, Hong Kong SAR, China.

出版信息

Child Neurol Open. 2015 May 26;2(2):2329048X15585345. doi: 10.1177/2329048X15585345. eCollection 2015 Apr-Jun.

DOI:10.1177/2329048X15585345
PMID:28503591
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5417024/
Abstract

The aim of this collaborative study on Duchenne muscular dystrophy and Becker muscular dystrophy is to determine the prevalence and to develop data on such patients as a prelude to the development of registry in Hong Kong. Information on clinical and molecular findings, and patient care, was systematically collected in 2011 and 2012 from all Pediatric Neurology Units in Hong Kong. Ninety patients with dystrophinopathy were identified, and 83% has Duchenne muscular dystrophy. The overall prevalence of dystrophinopathy in Hong Kong in 2010 is 1.03 per 10 000 males aged 0 to 24 years. Among the Duchenne group, we observed a higher percentage (40.6%) of point mutations with a lower percentage (45.3%) of exon deletions in our patients when compared with overseas studies. Although we observed similar percentage of Duchenne group received scoliosis surgery, ventilation support, and cardiac treatment when compared with other countries, the percentage (25%) of steroid use is lower.

摘要

这项关于杜氏肌营养不良症和贝克肌营养不良症的合作研究旨在确定其患病率,并收集此类患者的数据,作为在香港建立登记册的前奏。2011年和2012年,从香港所有儿科神经科收集了有关临床和分子研究结果以及患者护理的信息。共识别出90例肌营养不良蛋白病患者,其中83%患有杜氏肌营养不良症。2010年香港肌营养不良蛋白病在0至24岁男性中的总体患病率为每10000人中有1.03例。与海外研究相比,在杜氏组中,我们观察到患者的点突变百分比更高(40.6%),外显子缺失百分比更低(45.3%)。尽管与其他国家相比,我们观察到杜氏组接受脊柱侧弯手术、通气支持和心脏治疗的百分比相似,但使用类固醇的百分比(25%)较低。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7443/5417024/1263fe9539e5/10.1177_2329048X15585345-fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7443/5417024/78959b46fb34/10.1177_2329048X15585345-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7443/5417024/f888c60c4fe4/10.1177_2329048X15585345-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7443/5417024/1e4eebb0aad9/10.1177_2329048X15585345-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7443/5417024/ed4bc6916b96/10.1177_2329048X15585345-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7443/5417024/cec1db91aafc/10.1177_2329048X15585345-fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7443/5417024/1263fe9539e5/10.1177_2329048X15585345-fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7443/5417024/78959b46fb34/10.1177_2329048X15585345-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7443/5417024/f888c60c4fe4/10.1177_2329048X15585345-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7443/5417024/1e4eebb0aad9/10.1177_2329048X15585345-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7443/5417024/ed4bc6916b96/10.1177_2329048X15585345-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7443/5417024/cec1db91aafc/10.1177_2329048X15585345-fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7443/5417024/1263fe9539e5/10.1177_2329048X15585345-fig6.jpg

相似文献

1
Prevalence and Characteristics of Chinese Patients With Duchenne and Becker Muscular Dystrophy: A Territory Wide Collaborative Study in Hong Kong.中国杜氏和贝克肌营养不良症患者的患病率及特征:香港一项全地区协作研究
Child Neurol Open. 2015 May 26;2(2):2329048X15585345. doi: 10.1177/2329048X15585345. eCollection 2015 Apr-Jun.
2
[Genetic analysis and prenatal diagnosis of Duchenne or Becker muscular dystrophy].杜氏或贝克型肌营养不良症的基因分析与产前诊断
Zhonghua Fu Chan Ke Za Zhi. 2019 Apr 25;54(4):226-231. doi: 10.3760/cma.j.issn.0529-567x.2019.04.003.
3
Urological manifestations of Duchenne muscular dystrophy.杜氏肌营养不良症的泌尿系统表现。
J Urol. 2013 Oct;190(4 Suppl):1523-8. doi: 10.1016/j.juro.2013.01.059. Epub 2013 Jan 25.
4
Left ventricular noncompaction cardiomyopathy in Duchenne muscular dystrophy carriers.杜氏肌营养不良症携带者中的左心室心肌致密化不全心肌病
J Cardiol Cases. 2014 Oct 3;11(1):7-9. doi: 10.1016/j.jccase.2014.08.010. eCollection 2015 Jan.
5
Serum Creatinine Distinguishes Duchenne Muscular Dystrophy from Becker Muscular Dystrophy in Patients Aged ≤3 Years: A Retrospective Study.血清肌酐可区分3岁及以下患者的杜氏肌营养不良症和贝克肌营养不良症:一项回顾性研究
Front Neurol. 2017 May 8;8:196. doi: 10.3389/fneur.2017.00196. eCollection 2017.
6
Complementary and alternative medicine for Duchenne and Becker muscular dystrophies: characteristics of users and caregivers.杜兴氏和贝克氏肌营养不良症的补充和替代医学:使用者及护理者的特征
Pediatr Neurol. 2014 Jul;51(1):71-7. doi: 10.1016/j.pediatrneurol.2014.02.003. Epub 2014 Feb 15.
7
Cognitive and psychological profile of males with Becker muscular dystrophy.贝克型肌营养不良男性患者的认知和心理特征
J Child Neurol. 2008 Feb;23(2):155-62. doi: 10.1177/0883073807307975. Epub 2007 Dec 3.
8
Differentiation of Pediatric-Onset Duchenne and Becker Muscular Dystrophy Subphenotypes Using Data from the Muscular Dystrophy Surveillance Tracking and Research Network (MD STARnet).使用肌肉萎缩症监测、跟踪和研究网络(MD STARnet)的数据对儿科发病的杜氏和贝克型肌营养不良亚型进行区分。
J Neuromuscul Dis. 2022;9(1):171-178. doi: 10.3233/JND-210739.
9
Prevalence and Genetic Profile of Duchene and Becker Muscular Dystrophy in Puerto Rico.波多黎各杜氏和贝克型肌营养不良症的患病率和遗传特征。
J Neuromuscul Dis. 2016 May 27;3(2):261-266. doi: 10.3233/JND-160147.
10
Secondary Conditions Among Males With Duchenne or Becker Muscular Dystrophy.杜氏或贝克型肌营养不良男性患者的继发疾病
J Child Neurol. 2017 Jun;32(7):663-670. doi: 10.1177/0883073817701368. Epub 2017 Apr 9.

引用本文的文献

1
Research trends on spinal muscular atrophy from 1995 to 2023: A bibliometric analysis.1995年至2023年脊髓性肌萎缩症的研究趋势:一项文献计量分析。
Medicine (Baltimore). 2025 Mar 28;104(13):e41801. doi: 10.1097/MD.0000000000041801.
2
Global prevalence of Duchenne and Becker muscular dystrophy: a systematic review and meta-analysis.全球杜氏肌营养不良症和贝克肌营养不良症的患病率:系统评价和荟萃分析。
J Orthop Surg Res. 2022 Feb 15;17(1):96. doi: 10.1186/s13018-022-02996-8.
3
Combining Protein Expression and Molecular Data Improves Mutation Characterization of Dystrophinopathies.

本文引用的文献

1
The TREAT-NMD Duchenne muscular dystrophy registries: conception, design, and utilization by industry and academia.TREAT-NMD 杜氏肌营养不良症注册中心:概念、设计以及行业和学术界的利用。
Hum Mutat. 2013 Nov;34(11):1449-57. doi: 10.1002/humu.22390. Epub 2013 Aug 26.
2
Characteristics of Japanese Duchenne and Becker muscular dystrophy patients in a novel Japanese national registry of muscular dystrophy (Remudy).日本肌肉萎缩症新型全国登记系统(Remudy)中杜氏和贝克型肌肉萎缩症患者的特征
Orphanet J Rare Dis. 2013 Apr 19;8:60. doi: 10.1186/1750-1172-8-60.
3
Long-term benefits and adverse effects of intermittent versus daily glucocorticoids in boys with Duchenne muscular dystrophy.
结合蛋白质表达和分子数据可改善肌营养不良症的突变特征分析。
Front Neurol. 2021 Dec 7;12:718396. doi: 10.3389/fneur.2021.718396. eCollection 2021.
Duchenne 型肌营养不良症男孩中糖皮质激素间歇性与每日给药的长期获益和不良反应。
J Neurol Neurosurg Psychiatry. 2013 Jun;84(6):698-705. doi: 10.1136/jnnp-2012-303902. Epub 2012 Dec 18.
4
DuchenneConnect Registry Report.杜兴氏肌营养不良症关联注册报告。
PLoS Curr. 2012 Feb 29;4:RRN1309. doi: 10.1371/currents.RRN1309.
5
Efficacy and tolerance of gastrostomy feeding in Japanese muscular dystrophy patients.日本肌肉萎缩症患者胃造口喂养的疗效与耐受性
Brain Dev. 2012 Oct;34(9):756-62. doi: 10.1016/j.braindev.2011.11.012. Epub 2011 Dec 26.
6
Exon skipping and dystrophin restoration in patients with Duchenne muscular dystrophy after systemic phosphorodiamidate morpholino oligomer treatment: an open-label, phase 2, dose-escalation study.系统注射磷酰胺吗啉寡聚物治疗杜氏肌营养不良症患者的外显子跳跃和肌营养不良蛋白修复:一项开放标签、2 期、剂量递增研究。
Lancet. 2011 Aug 13;378(9791):595-605. doi: 10.1016/S0140-6736(11)60756-3. Epub 2011 Jul 23.
7
Current status of pharmaceutical and genetic therapeutic approaches to treat DMD.治疗 DMD 的药物和基因治疗方法的现状。
Mol Ther. 2011 May;19(5):830-40. doi: 10.1038/mt.2011.59. Epub 2011 Apr 5.
8
Read-through strategies for suppression of nonsense mutations in Duchenne/ Becker muscular dystrophy: aminoglycosides and ataluren (PTC124).杜氏/贝克型肌营养不良症中抑制无义突变的通读策略:氨基糖苷类药物和阿他芦醇(PTC124)
J Child Neurol. 2010 Sep;25(9):1158-64. doi: 10.1177/0883073810371129. Epub 2010 Jun 2.
9
Diagnosis and management of Duchenne muscular dystrophy, part 2: implementation of multidisciplinary care.杜氏肌营养不良症的诊断与管理,第 2 部分:多学科护理的实施。
Lancet Neurol. 2010 Feb;9(2):177-89. doi: 10.1016/S1474-4422(09)70272-8. Epub 2009 Nov 27.
10
Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management.杜氏肌营养不良症的诊断和管理,第 1 部分:诊断、药理学和心理社会管理。
Lancet Neurol. 2010 Jan;9(1):77-93. doi: 10.1016/S1474-4422(09)70271-6. Epub 2009 Nov 27.